HIMSS TV
David Champeaux, chief growth officer at Cherish Health and a member of the HIMSS UK Advisory Council, says not only is it important to design innovation into care ecosystems, but we must be able to ensure sustained adoption.
SPONSORED
Darine Ghanem, global head of personalized healthcare and patient access, global medical affairs, at Roche, discusses the need for digitalization of care across the patient journey and how her company is supporting the sector using digital technology.
Piotr Orzechowski, CEO at Infermedica, says the increased adoption of technology such as telemedicine has helped open up innovation opportunities.
SPONSORED
Alexander Ryan, Healthcare Alliances and Net New Sales Manager, EMEA, at Hyland, says many countries in Europe are investing heavily in transformation, while organizations are accelerating their implementation strategy due to COVID-19.
Dr. Bridget Duffy, former chief experience officer at the Cleveland Clinic and CMO at Vocera, talks about burnout during COVID-19, how to protect the healthcare workforce, and how technology can help and hurt with burnout.
In the midst of the pandemic, Ochsner Health organized, formatted and shared data for a "never again" scenario, says Amy Trainor, VP of IS clinical systems.
This week's top stories include the passing of Supreme Court Justice Ginsburg and what that could mean for the Affordable Care Act, femtech companies calling out Facebook and the emergence of social informatics.
Dr. Pam Hoffman, medical director of telehealth services at Yale New Haven Health Services and Yale Medicine, says telehealth became a service that required a "clinical champion" to a necessary part of the health system's offerings.
Nigel Hughes, scientific director RWD/RWE at Janssen Research and Development, says the pandemic presented both challenges and opportunities for real-world data generation surrounding scale, privacy and ethics.
Dr. Eric J. Rubin, editor-in-chief of the New England Journal of Medicine, discusses the challenges of maintaining rigorous editorial and medical standards while also exploring new ideas and concepts during COVID-19.

